CAS 3909-12-4

(2S,3R)-2,3,4-trihydroxybutanoic acid

Description:

(2S,3R)-2,3,4-trihydroxybutanoic acid, commonly known as L-threonic acid, is a naturally occurring organic compound characterized by its structure as a four-carbon dicarboxylic acid with three hydroxyl groups. This compound is a stereoisomer, specifically one of the two enantiomers of threonic acid, with specific configurations at the second and third carbon atoms. It is a white, crystalline solid that is soluble in water due to its multiple hydroxyl groups, which enhance its polarity. L-threonic acid is known for its role in biological systems, particularly as a metabolite of vitamin C (ascorbic acid) and is involved in various biochemical pathways. Its presence in certain fruits and vegetables contributes to its nutritional significance. Additionally, it has potential applications in the food and pharmaceutical industries, particularly as a stabilizing agent or in formulations requiring antioxidant properties. The compound's ability to form hydrogen bonds due to its hydroxyl groups also contributes to its reactivity and interactions in various chemical environments.

Formula: C₄H₈O₅

InChI: InChI=1/C4H8O5/c5-1-2(6)3(7)4(8)9/h2-3,5-7H,1H2,(H,8,9)/t2-,3+/m1/s1

InChI key: InChIKey=JPIJQSOTBSSVTP-FGNFWGHYNA-N

SMILES: [C@H]([C@@H](CO)O)(C(O)=O)O

Synonyms:

• Butanoic acid, 2,3,4-trihydroxy-, (2R,3S)-rel-
• Butanoic acid, 2,3,4-trihydroxy-, (R*,S*)-
• Threonic acid
• butanoic acid, 2,3,4-trihydroxy-, (2S,3R)-
• rel-(2R,3S)-2,3,4-Trihydroxybutanoic acid
• threo-2,3,4-Trihydroxybutyric acid
• (2S,3R)-2,3,4-Trihydroxybutanoic acid

Threonic acid

CAS: 3909-12-4

Threonic acid is a medicinal compound that has shown promising anticancer properties. It is an analog of vitamin C and can be found in human urine. Threonic acid works as a protein kinase inhibitor, which prevents cancer cells from dividing and growing. This compound has been studied extensively in Chinese medicine for its ability to induce apoptosis or programmed cell death in tumor cells. Threonic acid has been shown to inhibit the activity of several kinases, including Akt and ERK1/2, which are involved in cancer cell proliferation and survival. This inhibitor has the potential to become a valuable addition to cancer treatment regimens due to its ability to target multiple pathways involved in cancer development and progression.

Formula: C₄H₈O₅

Purity: Min. 95%

Molecular weight: 136.1 g/mol

Ref: 3D-DAA90912